Don’t miss FDA’s Chrissy Cochran, PhD, at the 2023 WCG Avoca Quality Consortium Summit
Announcing FDA Keynote Speaker, Chrissy Cochran, PhD
Chrissy J. Cochran, PhD, is Director of the Office of Bioresearch Monitoring Operations at the Food and Drug Administration (FDA) and is responsible for working with each of FDA’s product centers to manage the BIMO program.
At the Summit, Dr. Cochran’s keynote address will highlight recent BIMO updates as well as GCP inspection trends and metrics in order to move the clinical trial industry from knowledge to wisdom.
Now in its 12th year, the 2023 WCG Avoca Quality Consortium Summit offers a deep dive into clinical trial industry challenges in an increasingly complex environment, the imperative to leverage the knowledge we’ve acquired to develop the wisdom we need, and practical actions we can take to own the future. This industry-wide virtual event will feature expert speakers and executive panels, as well as perspectives from industry research and from all stakeholders across the clinical trial ecosystem.
Early bird pricing available through April 15!
The event will take place virtually on May 17-18, 2023, from 10:00am – 2:30pm EDT each day. Additionally, you will be able to access the content for 60 days to view at your convenience.
As a benefit of membership, each WCG Avoca Quality Consortium (AQC) member company receives up to four complimentary passes and a discounted rate for additional attendees. Not a member of the AQC? Click here to learn more.
2023 Summit Sponsors